QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today it has entered into an agreement to acquire N-of…
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today it has entered into an agreement to acquire N-of…
Clinical study demonstrates proof-of-concept for active personalized immunotherapy approach in a pioneering multi-center…
The prospect of an actively personalized approach to the treatment of glioblastoma has moved a step closer with the rece…
A total grant sum of EUR 2 million has been awarded to a multidisciplinary EUROSTARS consortium. The EUROSTARS project i…
Molecular Health (MH), a leading biomedical company that is transforming molecular data into clinically actionable infor…
Thermo Fisher Scientific, the world leader in serving science, today announced new laboratory automation technologies de…
BGI, one of the world’s leading genomics organisations, headquartered in Shenzhen, Guangdong, P. R. China, and Hummingbi…
GILUPI GmbH announces the release of a scientific article about the detection of circulating tumor cells (CTCs) from blo…
Tentamus Group, located in Berlin, provides tailored services to the food industry. Large investments in Technology and…
- Deal includes 100 additional 737 MAX 8s; 50 purchase rights - All-Boeing jet operator continues to grow fleet with mor…